| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10594757 | Bioorganic & Medicinal Chemistry Letters | 2010 | 4 Pages |
Abstract
The lead finding activities for a dual NK1/NK3 receptor antagonist discovery program, resulting in lead compounds with favourable pharmacological and pharmacokinetic properties, are described.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Jens-Uwe Peters, Torsten Hoffmann, Patrick Schnider, Heinz Stadler, Andreas Koblet, André Alker, Sonia Maria Poli, Theresa M. Ballard, Will Spooren, Lucinda Steward, Andrew J. Sleight,